Individual Glycation Sites as Biomarkers of Type 2 Diabetes Mellitus
Type 2 diabetes mellitus (T2DM) is a widely spread metabolic disease, the initial stages of which are asymptomatic and have no clinically recognizable manifestation. At the molecular level, T2DM is manifested with essential non-enzymatic structural changes of intra- and extracellular proteins, mostl...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2021
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/74868 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Individual Glycation Sites as Biomarkers of Type 2 Diabetes Mellitus
- Bio-Chemical Aspects, Pathophysiology of Microalbuminuria and Glycated Hemoglobin in Type 2 Diabetes Mellitus
- Dietary Advanced Glycation End-Products (AGES) Induced Complications in Type 1 Diabetes Mellitus
- Glycated hemoglobin correlates with inflammatory markers of cardiovascular risk in patients with type 2 diabetes mellitus
- Management of Type 2 Diabetes Mellitus
- Pharmacotherapy of Type 2 Diabetes Mellitus
- Exercise and Type 2 Diabetes Mellitus